This inventor holds 8 USPTO granted patents and 2 EPO patents. Top assignees: Inke, S.a., Vita-Invest S.a., Laboratorios Lesvi, S.l.. Active years: 1997-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sant Joan Despi, ES (1997 - 2011)
- Barcelona, ES (2010 - 2018)
Company Filing History:
Years Active: 1997-2024
Title: Joan Huguet Clotet: Innovator in Pharmaceutical Processes
Introduction
Joan Huguet Clotet is a notable inventor based in Sant Joan Despi, Spain. She has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. Her work focuses on improving processes for the preparation of various chemical compounds, which are essential in the development of medications.
Latest Patents
One of her latest patents is titled "Process for preparing 1-deoxy-1-methylamino-d-glucitol 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate." This invention relates to an improved method for producing tafamidis meglumine, which is particularly suitable for industrial-scale manufacture, ensuring excellent purity and high yields. Another significant patent is "Process for preparing (3RS)-3-[(2SR)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide." This invention presents an efficient and environmentally friendly process for preparing the compound with high yield and purity, making it suitable for industrial applications.
Career Highlights
Throughout her career, Joan has worked with various companies, including Inke, S.A. and Vita-Invest, S.A. Her experience in these organizations has contributed to her expertise in pharmaceutical processes and innovation.
Collaborations
Joan has collaborated with notable individuals in her field, including Pere Dalmases Barjoan and Juan Carlos Del Castillo Nieto. These collaborations have further enhanced her work and contributions to the industry.
Conclusion
Joan Huguet Clotet is a distinguished inventor whose work in pharmaceutical processes has led to significant advancements in the field. Her patents reflect her commitment to innovation and excellence in the development of essential medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile